Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Necrotizing Sweet syndrome: a new variant of neutrophilic dermatosis mimicking necrotizing fasciitis.
Iatrogenic skin injury in hospitalized patients.
An infant with pulmonary-cutaneous Sweet syndrome.
Case records of the Massachusetts General Hospital. Case 37-2009. A 46-year-old woman with chronic renal failure, leg swelling, and skin changes.
A survey assessment of the recognition and treatment of psychocutaneous disorders in the outpatient dermatology setting: how prepared are we?
Skin Diseases, Vesiculobullous
Skin Diseases, Infectious
Cutaneous calciphylaxis: a retrospective histopathologic evaluation.
Fingertip purpura in a dental student: an unusual manifestation of methyl methacrylate dermatitis.
PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
A case of eczematid-like purpura of Doucas and Kapetanakis in a child.
Vesiculobullous and hemorrhagic erythema migrans: uncommon variants of a common disease.
Association of Dermatology Consultation With Accuracy of Cutaneous Disorder Diagnoses in Hospitalized Patients: A Multicenter Analysis.
Infliximab-induced follicular mucinosis of the face.
Update on calciphylaxis etiopathogenesis, diagnosis, and management.
The ALT-70 cellulitis model maintains predictive value at 24 and 48 hours after presentation.
Correlation between clinical and pathological features of cutaneous calciphylaxis.
Dermatology consultation reduces interruption of oncologic management among hospitalized patients with immune-related adverse events: A retrospective cohort study.